FeaturedBiotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full ApprovalBy Ian YoungAugust 23, 2021
Innovative ETFs ChannelWill Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug?By Ian YoungJune 9, 2021
Equity ETF ChannelBiotech ETFs Make Gains Tuesday, Despite the J&J Vaccine PauseBy Ian YoungApril 13, 2021
FeaturedModerna Helps Biotech ETFs Mitigate Massive Losses as Stocks TumbleBy Ian YoungJanuary 4, 2021
FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
Nasdaq Portfolio Solutions ChannelA Junior Biotech ETF With Home Run PotentialBy Todd ShriberAugust 14, 2020
